secwatch.observer — SEC 8-K summary
======================================

Issuer:     Greenwich LifeSciences, Inc. (GLSI)
CIK:        0001799788
Form:       8-K
Filed at:   2022-07-12T23:59:59+00:00
Accession:  0001493152-22-019051
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Greenwich LifeSciences enters $100M ATM equity offering agreement with Jefferies
--------------------------------------------------------------------------------

- Entered Open Market Sale Agreement with Jefferies LLC for at-the-market offering of common stock up to $100M.
- Commission rate of up to 3.0% of gross proceeds; Jefferies gets customary indemnification.
- Proceeds intended for general corporate purposes including GP2 clinical development, R&D, working capital.
- No obligation to sell any shares; company can suspend offering.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799788/000149315222019051/0001493152-22-019051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799788/000149315222019051/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-019051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer